Physician profile
Scott B Sellinger
NPI 1740243526
$2,289,058.92
in general payments reported to CMS, 2019-2025
52 companies · $466K in 2025
The $466K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303K · 2020: $153K · 2021: $233K · 2022: $356K · 2023: $402K · 2024: $377K · 2025: $466K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $815K · Travel and Lodging: $243K · Consulting Fee: $118K · Honoraria: $42K · Food and Beverage: $27K · Education: $48.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $814,725.63 |
| Travel and Lodging | $243,010.19 |
| Consulting Fee | $118,115.09 |
| Honoraria | $41,850.00 |
| Food and Beverage | $27,008.67 |
| Education | $48.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $585,085.25 | 2019-2025 | Erleada, Akeega, Carvykti |
| Astrazeneca Pharmaceuticals Lp | $433,440.66 | 2021-2025 | Lynparza, Truqap |
| Astellas Pharma US INC | $315,217.30 | 2019-2025 | Xtandi, Veozah, Myrbetriq |
| Pfizer INC. | $254,419.61 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $245,695.23 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $87,427.37 | 2023-2025 | Orgovyx, Gemtesa |
| Tolmar Pharmaceuticals, INC. | $87,070.68 | 2019-2022 | |
| Myovant Sciences INC. | $76,598.02 | 2021-2022 | |
| Accord Healthcare, INC. | $39,717.84 | 2023-2025 | |
| Janssen Scientific Affairs, LLC | $25,645.61 | 2021-2025 | Erleada, Akeega |
| Tolmar, INC. | $16,754.33 | 2023-2025 | Eligard, Jatenzo |
| Ferring Pharmaceuticals INC. | $16,375.81 | 2019-2025 | Adstiladrin |
| Avyxa Pharma, LLC | $15,708.95 | 2025 | |
| Merck Sharp & Dohme LLC | $14,602.85 | 2019-2025 | Lynparza, Keytruda, Welireg |
| Dendreon Pharmaceuticals LLC | $14,156.10 | 2019-2025 | Provenge |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $13,304.34 | 2022-2025 | Darzalex, Rybrevant, Erleada |
| Progenics Pharmaceuticals, INC. | $11,169.26 | 2020-2025 | Pylarify |
| Novartis Pharmaceuticals Corporation | $7,957.00 | 2022-2025 | |
| Urogen Pharma, INC. | $6,442.39 | 2021-2024 | Jelmyto |
| Tempus Ai, INC | $5,283.69 | 2024-2025 | Xt Cdx |
| Amgen INC. | $4,907.08 | 2019-2023 | Xgeva, Prolia |
| Janssen Global Services, LLC | $3,282.50 | 2021 | |
| Clovis Oncology, INC. | $1,900.75 | 2019 | |
| Verity Pharmaceuticals INC. | $1,334.78 | 2022-2024 | Trelstar |
| E.R. Squibb & Sons, L.L.C. | $870.00 | 2021 | |
| Myriad Genetic Laboratories, INC. | $752.67 | 2021-2025 | Prolaris |
| Abbvie INC. | $612.23 | 2019-2025 | Botox, Lupron Depot |
| Allergan, INC. | $526.88 | 2019-2022 | |
| Blue Earth Diagnostics | $499.20 | 2022-2024 | |
| Boston Scientific Corporation | $477.18 | 2019-2025 | Axonics, Ams 700, Rezum Generator |
| Endo Pharmaceuticals INC. | $272.10 | 2019-2024 | Xiaflex, Edex, Aveed |
| Medtronic, INC. | $252.38 | 2021-2024 | Interstim |
| Antares Pharma, INC. | $220.00 | 2019-2025 | Xyosted |
| Axonics, INC. | $152.91 | 2020-2023 | Axonics |
| Telix Pharmaceuticals | $131.69 | 2022-2025 | Illuccix |
| Endo USA, INC. | $116.18 | 2024-2025 | Xiaflex, Aveed, Edex |
| Procept Biorobotics Corporation | $94.44 | 2024 | Aquabeam System |
| Foundation Medicine, INC. | $70.56 | 2023 | |
| Uronova Pharmaceuticals, INC. | $67.79 | 2025 | Vabrinty |
| Olympus America INC. | $63.31 | 2023-2025 | Itind System |
| Urovant Sciences INC | $53.06 | 2022 | |
| Caris Mpi, INC. | $51.05 | 2025 | Mi Cancer Seek |
| Cook Medical LLC | $45.29 | 2022-2024 | Cook |
| Karl Storz Endoscopy-America | $44.65 | 2020 | |
| Coloplast Corp | $44.43 | 2019-2024 | |
| Sun Pharmaceutical Industries INC. | $39.28 | 2025 | |
| Laborie Medical Technologies Corp. | $30.92 | 2024 | Eclipse, Endosheath Technology |
| Mimedx Group, INC. | $19.91 | 2024 | |
| Rochester Medical Corporation | $14.11 | 2022 | |
| Travere Therapeutics, INC. | $13.59 | 2019 | |
| Clarus Therapeutics INC. | $13.33 | 2021 | |
| Medtronic USA, INC. | $12.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Sellinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.